Info
Ownership

James Chopas - Insider Trading & Ownership

Location: 950 Winter Street, Waltham, MA
Summary: The estimated net worth of James Chopas is at least $1.19M dollars as of March 18, 2025. James Chopas is the VP/Chief Accounting Officer of Apellis Pharmaceuticals, Inc. and owns shares of Apellis Pharmaceuticals, Inc. (APLS) stock worth about $1.19M.
Signature: /s/ David Watson, attorney-in-fact for James Chopas
All Insider Reports: All Insider Reports

Ownership of James Chopas

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
APLS	Apellis Pharmaceuticals, Inc.	VP/Chief Accounting Officer	$1.19M	-$110K	-8.49%	Mar 17, 2025

Showing 1 to 1 of 1 entries

Insider Transactions Reported by James Chopas:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-0.38%	-$4.54K	24.82	-183	48K	3/17/2025	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-2.23%	-$33.3K	30.43	-1.1K	48.1K	1/22/2025	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Award	+34.4%	$0	0.00	+12.6K	49.2K	1/21/2025	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-1.91%	-$21.4K	29.96	-715	36.6K	1/17/2025	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-2.05%	-$22.5K	28.70	-783	37.4K	1/13/2025	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-0.5%	-$6.95K	36.21	-192	38.1K	9/16/2024	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-1.41%	-$21.7K	39.49	-550	38.3K	9/3/2024	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-0.47%	-$10.4K	56.46	-184	38.9K	3/15/2024	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-2.64%	-$69K	65.00	-1.06K	39.1K	1/22/2024	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-2.11%	-$57.7K	66.81	-864	40.1K	1/16/2024	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Award	+25.4%	$0	0.00	+8.31K	41K	1/16/2024	Direct
APLS	Apellis Pharmaceuticals, Inc.	Stock Option (Right to Buy)	Award		$801K	66.30	+12.1K	12.1K	1/16/2024	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-0.4%	-$6.08K	46.04	-132	32.7K	10/23/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Award	+8.25%	$0	0.00	+2.5K	32.8K	9/14/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Sale	-1.79%	-$22.7K	41.23	-551	30.3K	8/31/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Tax liability	-1.07%	-$19.5K	58.50	-334	30.9K	2/21/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Award	+14.9%	$0	0.00	+4.04K	31.2K	2/21/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+5.74K	5.74K	2/21/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Tax liability	-3.27%	-$47.8K	52.05	-919	27.2K	1/20/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Award	+52.1%	$0	0.00	+9.62K	28.1K	1/12/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Stock Option (Right to Buy)	Award		$796K	52.66	+15.1K	15.1K	1/12/2023	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Tax liability	-0.7%	-$7.54K	58.00	-130	18.5K	10/20/2022	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Tax liability	-2.92%	-$32.8K	58.84	-558	18.6K	8/30/2022	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Award	+125.6%	$0	0.00	+10.7K	19.1K	1/21/2022	Direct
APLS	Apellis Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+15.1K	15.1K	1/21/2022	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Award	+11.6%	$0	0.00	+882	8.48K	10/20/2021	Direct
APLS	Apellis Pharmaceuticals, Inc.	Common Stock	Award		$0	0.00	+7.6K	7.6K	8/30/2021	Direct
APLS	Apellis Pharmaceuticals, Inc.	Stock Option (right to buy)	Award		$0	0.00	+21.8K	21.8K	8/30/2021	Direct

Previous1Next

Showing 1 to 28 of 28 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.